Hepatic Medicine-Evidence and Research is a distinguished open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing knowledge in the field of hepatology. Since its inception in 2009, this journal has served as a critical platform for researchers, professionals, and students alike, facilitating the dissemination of high-quality, peer-reviewed articles that address the latest developments in hepatic medicine. With a commitment to accessibility, all articles are freely available to a global audience, thereby promoting collaboration and innovation in research. Although specific metrics such as H-index and Scopus ranks are currently undeclared, the journal is recognized for its contributions to clinical practice and ongoing research in liver health, making it an essential resource for those seeking to enhance their understanding of hepatic conditions and treatments. By prioritizing the latest evidence and research in this vital field, Hepatic Medicine-Evidence and Research continues to play a pivotal role in influencing clinical outcomes and shaping future studies.

Current Opinion in Critical Care, published by Lippincott Williams & Wilkins, is a leading journal in the field of Critical Care and Intensive Care Medicine. With an ISSN of 1070-5295 and an E-ISSN of 1531-7072, this esteemed journal has been committed to disseminating high-quality and impactful research since its inception in 1996. The journal proudly ranks in the top quartile (Q1) of its category for 2023, affirming its position among the premier publications in critical care, with a Scopus ranking of #25 out of 110, placing it in the 77th percentile. Current Opinion in Critical Care offers essential insights, reviews, and discussions on the latest trends and best practices in the field, catering to the needs of researchers, clinicians, and students alike. Though it does not provide open access options, its contributions are pivotal in shaping patient care approaches and advancing clinical outcomes in critical care settings.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

The Journal of Intensive Care, published by BMC, is a leading open access journal dedicated to advancing research and knowledge in the fields of critical care and intensive care medicine. With an impressive 2023 rank of #11 out of 110 in its category and placing in the 90th percentile, this journal offers a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and best practices. Launched in 2013, the journal has gained significant recognition, achieving a Q1 quartile ranking in critical care, reflecting its commitment to high-quality contributions that address pressing issues in patient management and care. Additionally, as an open access publication, the journal ensures that its content is widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those engaged in intensive care, the Journal of Intensive Care is an essential resource for staying abreast of the latest research trends and clinical advancements.

JOURNAL OF INTENSIVE CARE MEDICINE, published by SAGE PUBLICATIONS INC, is a leading peer-reviewed journal dedicated to advancing the field of critical care and intensive medicine. With an ISSN of 0885-0666 and an E-ISSN of 1525-1489, this esteemed journal showcases innovative research, clinical practices, and synthesis of knowledge that informs the complexities of patient care in intensive settings. Recognized for its exceptional impact, it holds a prestigious Q1 ranking in the Critical Care and Intensive Care Medicine category, landing in the upper 15% of its field according to Scopus rankings. Celebrating over three decades of publication since its inception in 1986, the journal serves both as a resource for seasoned professionals and a platform for emerging researchers eager to contribute to evidence-based practice. Although not open access, the journal ensures that critical insights and advancements are accessible to a broad audience, fostering a collaborative environment that is essential for the evolution of intensive care protocols and the enhancement of patient outcomes. With its commitment to excellence, the JOURNAL OF INTENSIVE CARE MEDICINE stands out as an invaluable resource that continues to shape the future of healthcare in critical domains.

Intensive Care Medicine Experimental is a premier open-access journal dedicated to advancing research and clinical practice within the realms of critical care, intensive care medicine, and emergency medicine. Published by SPRINGER, this influential journal has been committed to dispensing high-quality, peer-reviewed research since its inception in 2013, reflecting its progressive approach to open-access publishing and enhancing global accessibility to vital medical information. With a notable impact factor and categorically established Q1 rankings in both Critical Care and Emergency Medicine, as well as Q2 in Physiology (medical), the journal underscores its significance in disseminating groundbreaking studies and innovations. Positioned prominently within the medical literature, Intensive Care Medicine Experimental ranks 16th in Emergency Medicine and 27th in Critical Care, providing a vital platform for researchers, clinicians, and students alike to explore and share cutting-edge research findings that aim to improve patient outcomes. The journal's dedication to fostering collaboration and dialogue among professionals makes it an essential resource in the evolving landscape of intensive care and emergency medical disciplines.

CRITICAL CARE CLINICS is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on advancing knowledge in the fields of Critical Care and Intensive Care Medicine. With an impressive impact factor and designated as Q1 in both Critical Care and Intensive Medicine categories, this journal is a leading resource for healthcare professionals, researchers, and students alike. Since its establishment in 1985, it has evolved into an essential conduit for cutting-edge research, clinical insights, and evidence-based practices, bridging the gap between theoretical understanding and practical application in critical care. The journal maintains a high ranking, being positioned 15th of 110 in its category according to Scopus, with a noteworthy percentile of 86, indicating its influence and relevance in contemporary medical discourse. Although the journal is not open access, it provides valuable content for those dedicated to enhancing patient care and advancing the science of critical medicine. Its commitment to excellence makes it a vital resource for anyone engaged in the dynamic field of critical care.

BMC Cardiovascular Disorders is a premier open access journal dedicated to the field of cardiology and cardiovascular medicine, published by BMC, a leading publisher in the scientific community. Since its inception in 2001, this journal has provided a platform for high-quality research, showcasing innovative studies and critical reviews that contribute to the understanding and management of cardiovascular diseases. With an impressive impact factor and a rank in the Q2 category for 2023 within its field, BMC Cardiovascular Disorders stands at the forefront of cardiovascular research, enabling accessibility to a wealth of information that fosters collaboration and advancements in patient care. The journal's commitment to open access ensures that research is widely disseminated and easily accessible to researchers, practitioners, and students globally, enhancing the dialogue around cardiovascular health and disease prevention. Located in the United Kingdom, BMC Cardiovascular Disorders consistently aims to promote excellence in the study and treatment of cardiovascular conditions, encouraging the exchange of knowledge that ultimately benefits public health.

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

Sarcoidosis Vascularitis and Diffuse Lung Diseases is a prestigious academic journal published by Mattioli 1885, focusing on the interdisciplinary study of sarcoidosis, vasculitis, and various diffuse lung diseases. Since its inception in 1996, this journal has been pivotal in disseminating vital research findings, clinical experiences, and comprehensive reviews related to these complex conditions, supporting health professionals and researchers in advancing their understanding and treatment approaches. With a convergence period extending to 2024, the journal has gained recognition in multiple categories, including Q4 in Immunology and Allergy, and Q3 rankings in Internal Medicine, Medicine (Miscellaneous), and Pulmonary and Respiratory Medicine, reflecting its commitment to high-quality and impactful studies. Although currently not offering open access, its contributions are indispensable for the academic community, making it a vital resource for those dedicated to improving patient outcomes and fostering knowledge in the field.